Reply to BRCA2‐associated pancreatic cancer and current screening guidelines

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|17|3047-3047

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.17, 2015-09, pp. : 3047-3047

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

BRCA2‐associated pancreatic cancer and current screening guidelines

By  

CANCER, Vol. 121, Iss. 17, 2015-09 ,pp. : 3046-3046

John Wiley & Sons Inc

Access to resources Recommend Favorite

BRCA1 and BRCA2 germline mutations are frequently demonstrated in both high‐risk pancreatic cancer screening and pancreatic cancer cohorts

By  

CANCER, Vol. 120, Iss. 13, 2014-07 ,pp. : 1960-1967

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pancreatic Cancer in Hereditary Pancreatitis: Consensus Guidelines for Prevention, Screening and Treatment

By  

Pancreatology, Vol. 1, Iss. 5, 2001-09 ,pp. : 416-422

Karger

Access to resources Recommend Favorite

Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening

By  

CA: A CANCER JOURNAL FOR CLINICIANS, Vol. 65, Iss. 1, 2015-01 ,pp. : 30-54

John Wiley & Sons Inc

Access to resources Recommend Favorite

Off the mark: Current lung cancer screening guidelines miss those most at risk

By  

CANCER, Vol. 121, Iss. 15, 2015-08 ,pp. : 2477-2478

John Wiley & Sons Inc

Access to resources Recommend Favorite